Improving the health of children is my passion
Medical Research Scientist (Group Leader)
A/Prof Ignjatovic leads a highly productive, internationally competitive research laboratory in the field of paediatric thrombosis and haemostasis at the Murdoch Childrens Research Institute. She is a pioneer in this field, having defined the clinical and biological importance of developmental haemostasis, the concept describing age-specific differences in the haemostatic system and their implications for anticoagulation treatment in children. A/Prof Ignjatovic utilises innovative research approaches to develop novel strategies for thrombosis prevention and treatment in children. She is driven to make a significant impact on major health outcomes for children, by providing tailored prevention and treatment options. A/Prof Ignjatovic is the co-founder of the Paediatric Proteomics (PediOme) initiative through the Human Proteome Organisation (HUPO) and is the proteomics consultant on projects ranging from lung injury in prematurity to vascular malformations. She invests significant effort into supervising and mentoring students. She has over 100 publications; has been invited to present at conferences on 4 Continents. A/Prof Ignjatovic has received awards from the International Society on Thrombosis and Haemostasis (ISTH), Human Proteome Organisation (HUPO) and Australian Academy of Science. She is the Chair of the Paediatric Proteomics (PediOme) initiative and co-chair of the Plasma Proteome Project for HUPO is on editorial boards of Thrombosis and Haemostasis (section editor) and Thrombosis Research and is a member of the organizing committee for the ISTH 2019 Congress in Melbourne.